Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis

Fig. 2

Overall survival in patients 61–65 years of age receiving ASCT. Blue curve: Patients who started treatment in the period 01.01.2001–31.06.2005 (n = 32). Median overall survival = 57.3 months. Green curve = Patients who started treatment in the period 01.07.2005–31.12.2009 (n = 49). Median overall survival = 61.2 months. (p = 0,87(ns))

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us